RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Nashville, TN · +73 more sites
Type 2 Diabetes clinical trials in Nashville, TN
15 recruiting type 2 diabetes studies with a site in Nashville, TN.
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Clarksville, TN · Nashville, TN · +42 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Nashville, TN · +39 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Jackson, TN · Kingsport, TN · Memphis, TN · +96 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Nashville, TN · +40 more sites
RecruitingPhase 1 / Phase 2NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Sponsor: Aulos Bioscience, Inc.
Nashville, TN · +9 more sites
RecruitingPhase 3NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Kingsport, TN · Nashville, TN · +38 more sites
RecruitingPhase 4NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Sponsor: Brigham and Women's Hospital
Nashville, TN · +35 more sites
RecruitingPhase not listedNCT06481904
Registry for Stage 2 Type 1 Diabetes
Sponsor: Sanofi
Bartlett, TN · Nashville, TN · +35 more sites
RecruitingNot applicableNCT06852950
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Sponsor: Vanderbilt University Medical Center
Nashville, TN
RecruitingEarly Phase 1NCT06609356
Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
Sponsor: Vanderbilt University Medical Center
Nashville, TN
RecruitingEarly Phase 1NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Sponsor: Vanderbilt University Medical Center
Nashville, TN
RecruitingPhase not listedNCT05000996
Gut Microbiota in Metabolic Surgery
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Not yet recruitingPhase 3NCT07668336
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Nashville, TN · +16 more sites
Not yet recruitingPhase 2NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.